Ditchcarbon
  • Customers
  1. Organizations
  2. DiscGenics, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

DiscGenics, Inc.

Company website

DiscGenics, Inc., a pioneering biotechnology firm headquartered in the United States, focuses on developing innovative regenerative therapies for spinal disc degeneration. Founded in 2013, the company has made significant strides in the field of orthobiologics, particularly with its flagship product, IDCT, a cell-based therapy designed to restore disc health and alleviate pain. With a strong presence in the US and expanding operations in key international markets, DiscGenics is positioned at the forefront of the regenerative medicine industry. The company’s unique approach combines advanced cellular technology with a commitment to improving patient outcomes, setting it apart from traditional treatment options. Notable achievements include successful clinical trials that underscore the efficacy of its therapies, solidifying DiscGenics' reputation as a leader in spinal health innovation.

DitchCarbon Score

How does DiscGenics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

DiscGenics, Inc.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

DiscGenics, Inc.'s reported carbon emissions

DiscGenics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As such, there are no significant achievements or commitments to report regarding their carbon footprint or climate initiatives. Given the lack of emissions data and reduction initiatives, it is unclear how DiscGenics, Inc. aligns with industry standards for climate action. The company may need to establish clear climate commitments and set measurable targets to enhance its sustainability profile and contribute to broader environmental goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DiscGenics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for DiscGenics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

DiscGenics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ferring B.V.

NL
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Aesculap Implant Systems, Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 14 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 16 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Spine BioPharma, Inc.

US
•
Food waste for treatment: composting and land application
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy